Skip to main content
Journal cover image
Translational Immunotherapy of Brain Tumors

Immunotoxin Therapy for Brain Tumors

Publication ,  Chapter
Chandramohan, V; Sampson, JH; Pastan, IH; Bigner, DD
March 2, 2017

Despite a multimodal approach involving surgery, radiotherapy, and chemotherapy, the median survival for malignant brain tumor patients is limited to 15-19. months. To improve glioblastoma patient survival, novel therapies targeting the heterogeneous tumor cell population are needed. Advances in understanding the molecular features of patients' tumors have led to the development of personalized tumor-targeted therapies that are more effective and less toxic. Immunotoxins, a novel class of antibody/ligand-toxin conjugates, have been developed during the last two decades for the treatment of brain tumors. The antibody/ligand domain of the immunotoxin binds to the target antigen on the tumor cell surface, whereas the toxin payload kills the tumor cells by inhibiting protein synthesis. Advances in immunotoxin delivery and monitoring of immunotoxin distribution in tumors are overcoming the challenges in the brain tumor therapy field. Herein, we summarize the different antiglioma immunotoxins that are at the preclinical and clinical stages of development.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

ISBN

9780128024201

Publication Date

March 2, 2017

Start / End Page

227 / 260
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Chandramohan, V., Sampson, J. H., Pastan, I. H., & Bigner, D. D. (2017). Immunotoxin Therapy for Brain Tumors. In Translational Immunotherapy of Brain Tumors (pp. 227–260). https://doi.org/10.1016/B978-0-12-802420-1.00010-7
Chandramohan, V., J. H. Sampson, I. H. Pastan, and D. D. Bigner. “Immunotoxin Therapy for Brain Tumors.” In Translational Immunotherapy of Brain Tumors, 227–60, 2017. https://doi.org/10.1016/B978-0-12-802420-1.00010-7.
Chandramohan V, Sampson JH, Pastan IH, Bigner DD. Immunotoxin Therapy for Brain Tumors. In: Translational Immunotherapy of Brain Tumors. 2017. p. 227–60.
Chandramohan, V., et al. “Immunotoxin Therapy for Brain Tumors.” Translational Immunotherapy of Brain Tumors, 2017, pp. 227–60. Scopus, doi:10.1016/B978-0-12-802420-1.00010-7.
Chandramohan V, Sampson JH, Pastan IH, Bigner DD. Immunotoxin Therapy for Brain Tumors. Translational Immunotherapy of Brain Tumors. 2017. p. 227–260.
Journal cover image

DOI

ISBN

9780128024201

Publication Date

March 2, 2017

Start / End Page

227 / 260